Lineage Cell Therapeutics, Inc 10-K for FY2023
Lineage Cell Therapeutics, Inc. (LCTX)
10-K
2024-03-07
For: 2023-12-31
View Original
Added on
April 12, 2026
About this 10-K
Lineage Cell Therapeutics, Inc filed this 10-K on March 7, 2024, covering the fiscal year ended December 31, 2023 (FY2023).
Headline figures
Fiscal year ended December 31, 2023, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $8.95M
- down 39.2% from $14.7M a year earlier
- Net loss
- $21.49M
- compared with a net loss of $26.27M a year earlier
- Diluted EPS
- -$0.12
- compared with -$0.15 a year earlier